Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin E Ferner

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
BMJ (Clinical Research Ed.)|April 4, 2020
Drugs and the renin-angiotensin system in covid-19Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|December 16, 2016
Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)-variants in the spellings of drug names in PubMed: a database reviewRobin E Ferner, Jeffrey K Aronson
Current Protocols in Pharmacology|March 18, 2017
Biomarkers-A General ReviewJeffrey K Aronson, Robin E Ferner
Drug Safety|December 17, 2009
EIDOS: a mechanistic classification of adverse drug effectsRobin E Ferner, Jeffrey K Aronson
Diabetic Medicine : a Journal of the British Diabetic Association|March 2, 2023
Treatment of insulin poisoning: A 100-year reviewEmma J Moyns, Robin E Ferner
Drug Safety|May 1, 2024
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational TherapeuticsRobin E Ferner, Jeffrey K Aronson
BMJ (Clinical Research Ed.)|April 20, 2002
Using drugs safelySimon Maxwell, Tom Walley, Robin E Ferner
British Journal of Clinical Pharmacology|July 17, 2023
Drug shortages. Part 2: Trends, causes and solutionsJeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety|December 18, 2019
Medical Devices: Definition, Classification, and Regulatory ImplicationsJeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety|January 24, 2012
Deriving dose limits for warnings in electronic prescribing systems: statistical analysis of prescription data at University Hospital Birmingham, UKJamie J Coleman, James Hodson, Robin E Ferner
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
BMJ (Clinical Research Ed.)|April 4, 2020
Drugs and the renin-angiotensin system in covid-19Jeffrey K Aronson, Robin E Ferner
BMJ (Clinical Research Ed.)|December 16, 2016
Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)-variants in the spellings of drug names in PubMed: a database reviewRobin E Ferner, Jeffrey K Aronson
Current Protocols in Pharmacology|March 18, 2017
Biomarkers-A General ReviewJeffrey K Aronson, Robin E Ferner
Drug Safety|December 17, 2009
EIDOS: a mechanistic classification of adverse drug effectsRobin E Ferner, Jeffrey K Aronson
Diabetic Medicine : a Journal of the British Diabetic Association|March 2, 2023
Treatment of insulin poisoning: A 100-year reviewEmma J Moyns, Robin E Ferner
Drug Safety|May 1, 2024
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational TherapeuticsRobin E Ferner, Jeffrey K Aronson
BMJ (Clinical Research Ed.)|April 20, 2002
Using drugs safelySimon Maxwell, Tom Walley, Robin E Ferner
British Journal of Clinical Pharmacology|July 17, 2023
Drug shortages. Part 2: Trends, causes and solutionsJeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety|December 18, 2019
Medical Devices: Definition, Classification, and Regulatory ImplicationsJeffrey K Aronson, Carl Heneghan, Robin E Ferner
Drug Safety|January 24, 2012
Deriving dose limits for warnings in electronic prescribing systems: statistical analysis of prescription data at University Hospital Birmingham, UKJamie J Coleman, James Hodson, Robin E Ferner
Pageof 10